Things We Do for No Reason™: Universal Venous Thromboembolism Chemoprophylaxis in Low-Risk Hospitalized Medical Patients-Reference-Cited by-同舟云学术

Things We Do for No Reason™: Universal Venous Thromboembolism Chemoprophylaxis in Low-Risk Hospitalized Medical Patients

Published:2020-12-23 Issue:5 Volume:16 Page:
ISSN:1553-5606
Container-title:Journal of Hospital Medicine
language:
Short-container-title:J Hosp Med

Author:

Barlow Brooke,Barlow Ashley,Breu Anthony C

Publisher

Wiley

Subject

Assessment and Diagnosis,Care Planning,Health Policy,Fundamentals and skills,General Medicine,Leadership and Management

Link

https://cdn.mdedge.com/files/s3fs-public/issues/articles/barlow00891223e.pdf

Reference19 articles.

1. 1. Francis CW. Clinical practice. prophylaxis for thromboembolism in hospitalized medical patients. N Engl J Med. 2007;356(14):1438-1444. https://doi.org/10.1056/nejmcp067264

2. 2. Mahan CE, Borrego ME, Woersching AL, et al. Venous thromboembolism: annualised United States models for total, hospital-acquired and preventable costs utilising long-term attack rates. Thromb Haemost. 2012;108(2):291-302. https://doi.org/10.1160/th12-03-0162

3. 3. Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):e195S-e226S. https://doi.org/10.1378/chest.11-2296

4. 4. Wein L, Wein S, Haas SJ, Shaw J, Krum H. Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients: a meta-analysis of randomized controlled trials. Arch Intern Med. 2007;167(14):1476-1486. https://doi.org/10.1001/archinte.167.14.1476

5. 5. Performance Measurement. The Joint Commission. Accessed November 8, 2019. http://www.jointcommission.org/PerformanceMeasurement/PerformanceMeasurement/VTE.htm